Friday, July 31, 2026

SHADOWS ON THE WAVES : Deciphering The Strategic Signal Of Kim’s Latest Naval Strike

Kim Jong Un supervised a sea-to-ground missile test launch from a ship, as reported by North Korea's Rodong Sinmun.

BREAD OR BRICKS? : Why Kim Jong Un Is Spending Billions On Empty Skyscraper Shells While His People Starve

North Korea plans to build hundreds of thousands of housing units over five years, expanding on previous construction efforts.

U.S. Defense Strategy Shift: What Does It Mean for Korea’s Security in 2026?

U.S. Deputy Secretary Colby's visit to South Korea signals a shift in defense strategy, focusing on China and altering military exercises.

Tag: Cartistem

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us